Search

Displaying results 4291 - 4300 of 5383 in total
  1. Drug

    Ocaperidone

    go.drugbank.com/drugs/DB06229
    Experimental

  2. Drug

    Relacatib

    go.drugbank.com/drugs/DB06367
    Investigational

  3. Drug

    NRP290

    go.drugbank.com/drugs/DB06383
    Experimental

    NRP290 is a hydrocodone derivative under investigation for the treatment of pain (moderate to moderately severe).

  4. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

  5. Drug

    Mitumomab

    go.drugbank.com/drugs/DB06462
    Experimental

    Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.

  6. Drug

    IR502

    go.drugbank.com/drugs/DB06463
    Experimental

    IR502 (Zorcell) is a potential treatment for psoriasis.

  7. Drug

    Sufugolix

    go.drugbank.com/drugs/DB06494
    Experimental

  8. Drug

    Muraglitazar

    go.drugbank.com/drugs/DB06510
    Investigational

    Muraglitazar (Bristol-Myers Squibb/Merck) is a new agent under investigation for the treatment of patients with type 2 diabetes. It belongs to a novel class of drugs that target the peroxisome proliferator-activated receptors, both alpha...

  9. Drug

    AMGN-0007

    go.drugbank.com/drugs/DB06511
    Experimental

    Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.

  10. Drug

    Ragaglitazar

    go.drugbank.com/drugs/DB06533
    Experimental